Cooper Financial Group Edwards Lifesciences Corp Transaction History

Cooper Financial Group

$907 Million
Q4 2025

A detailed history of Cooper Financial Group transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Cooper Financial Group holds 4,653 shares of EW stock, worth $401,553. This represents 0.04% of its overall portfolio holdings.

Number of Shares

4,653

Previous 4,657 0.09%

Holding current value

$401,553

Previous $362,000 10.77%

% of portfolio

0.04%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 07, 2026	SELL	$72.65 - $86.3 $290 - $345	-4 Reduced 0.09%	4,653 $401,000
Q3 2025 Oct 07, 2025	SELL	$73.75 - $81.83 $8,260 - $9,164	-112 Reduced 2.35%	4,657 $362,000
Q2 2025 Jul 17, 2025	BUY	$67.07 - $78.22 $319,856 - $373,031	4,769 New	4,769 $372,000
Q4 2024 Jan 13, 2025	BUY	$64.54 - $75.92 $11,294 - $13,286	175 Added 2.78%	6,466 $478,000
Q3 2024 Nov 14, 2024	SELL	$59.7 - $93.78 $5,432 - $8,533	-91 Reduced 1.43%	6,291 $415,000

Q2 2024 Jul 15, 2024	BUY	$84.3 - $94.31 $180,233 - $201,634	2,138 Added 50.38%	6,382 $589,000
Q1 2024 Apr 11, 2024	BUY	$72.54 - $95.56 $145 - $191	2 Added 0.05%	4,244 $405,000
Q4 2023 Jan 16, 2024	BUY	$61.71 - $77.76 $30,361 - $38,257	492 Added 13.12%	4,242 $323,000
Q3 2023 Oct 13, 2023	BUY	$69.28 - $93.38 $259,800 - $350,175	3,750 New	3,750 $259,000
Q4 2022 Jan 13, 2023	SELL	$68.3 - $87.44 $273 - $349	-4 Reduced 0.11%	3,690 $0
Q3 2022 Oct 13, 2022	SELL	$82.37 - $107.29 $6,836 - $8,905	-83 Reduced 2.2%	3,694 $305,000
Q2 2022 Jul 11, 2022	BUY	$86.5 - $128.27 $7,525 - $11,159	87 Added 2.36%	3,777 $359,000
Q4 2021 Feb 11, 2022	SELL	$106.37 - $130.68 $80,096 - $98,402	-753 Reduced 16.95%	3,690 $478,000
Q2 2021 Jul 12, 2021	BUY	$83.84 - $104.76 $55,585 - $69,455	663 Added 17.54%	4,443 $460,000
Q4 2020 Feb 16, 2021	BUY	$71.69 - $91.23 $20,790 - $26,456	290 Added 8.31%	3,780 $345,000
Q3 2020 Oct 09, 2020	SELL	$67.19 - $87.44 $49,653 - $64,618	-739 Reduced 17.47%	3,490 $279,000
Q2 2020 Jul 15, 2020	BUY	$57.54 - $76.95 $243,336 - $325,421	4,229 New	4,229 $292,000
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $68,237 - $105,462	-1,302 Closed	0 $0
Q4 2019 Jan 07, 2020	BUY	$71.7 - $82.09 $430 - $492	6 Added 0.46%	1,302 $304,000
Q3 2019 Oct 08, 2019	BUY	$61.55 - $75.43 $5,724 - $7,014	93 Added 7.73%	1,296 $285,000
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $57,611 - $77,052	1,203 New	1,203 $230,000

Others Institutions Holding EW

# of Institutions

1,460

Shares Held

468M

Call Options Held

3.46M

Put Options Held

4.07M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $53.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cooper Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Cooper Financial Group with notifications on news.

Account

Cooper Financial Group Edwards Lifesciences Corp Transaction History